Form 4: Abeona Therapeutics SVP, General Counsel Brendan O'Malley Reports Stock Disposal for Tax Obligations

Brendan O'Malley, SVP and General Counsel of Abeona Therapeutics, disposed of 181 shares of common stock on March 3, 2025, to cover tax withholding obligations upon vesting of restricted stock.

Summary

• On March 3, 2025, Brendan O'Malley, the SVP and General Counsel of Abeona Therapeutics, disposed of 181 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock.
• The shares were disposed of at a price of $5.24 per share.
• Following the transaction, O'Malley directly owns 388,715 shares of Abeona Therapeutics common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as this is a routine transaction related to tax obligations and doesn't indicate a change in the executive's confidence in the company.

Industry Context

This is a routine Form 4 filing related to stock transactions by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a small disposal of shares to cover tax obligations.

Key Dates

Keywords

Form 4, Abeona Therapeutics, ABEO, Brendan O'Malley, Stock Disposal, Tax Withholding, Restricted Stock, Beneficial Ownership, SEC Filing